Long‐term clinical outcomes and healthcare resource utilization in male and female patients following hospitalization for heart failure
Tauben Averbuch,Shun Fu Lee,Brandon Zagorski,Ambarish Pandey,Mark C. Petrie,Tor Biering‐Sorensen,Feng Xie,Harriette G.C. Van Spall
DOI: https://doi.org/10.1002/ejhf.3499
2024-11-07
European Journal of Heart Failure
Abstract:Clinical outcomes and resource utilization in the 5 years following hospitalization for heart failure (HF), separated by sex. All‐cause readmission and mortality were common following HF hospitalization, and a majority of deaths occurred in the hospital, with no significant differences between male and female patients. While overall costs were similar between male and female patients, costs relating to specialist billings and day surgical procedures were higher among male patients, and costs relating to long‐term and home care were higher among female patients. Hospital readmission costs (not including in‐patient physician costs) accounted for nearly half the total cost of care. LVEF, left ventricular ejection fraction. Aims Heart failure (HF) is a leading cause of hospitalization, and sex differences in care have been described. We assessed sex‐specific clinical outcomes and healthcare resource utilization following hospitalization for HF. Methods and results This was an exploratory analysis of patients hospitalized for HF across 10 Canadian hospitals in the Patient‐Centered Care Transitions in HF (PACT‐HF) cluster‐randomized trial. The primary outcome was all‐cause mortality. Secondary outcomes included all‐cause readmissions, HF readmissions, emergency department (ED) visits, and healthcare resource utilization. Outcomes were obtained via linkages with administrative datasets. Among 4441 patients discharged alive, 50.7% were female. By 5 years, 63.6% and 65.5% of male and female patients, respectively, had died (p = 0.19); 85.4% and 84.4%, respectively, were readmitted (p = 0.35); and 72.2% and 70.9%, respectively, received ED care without hospitalization (p = 0.34). There were no sex differences in mean [SD] number of all‐cause readmissions (males, 2.8 [7.8] and females, 3.0 [8.4], p = 0.54), HF readmissions (males, 0.9 [3.6] and females, 0.9 [4.5], p = 0.80), or ED visits (males, 1.8 [11.3] and females, 1.5 [6.0], p = 0.24) per person. There were no sex differences in mean [SD] annual direct healthcare cost per patient (males, 81 010 [112 625], p = 0.90), but males received more specialist, multidisciplinary HF clinic, haemodialysis, and day surgical care, and females received more home visits, continuing/convalescent care, and long‐term care. Annualized clinical events were highest in first year following index discharge in both males and females. Conclusions Among people discharged alive after hospitalization for HF, there were no sex differences in total and annual deaths, readmissions, and ED visits, or in total direct healthcare costs. Despite similar risk profiles, males received relatively more specialist care and day surgical procedures, and females received more supportive care. Clinical Trial Registration: ClinicalTrials.gov NCT02112227.
cardiac & cardiovascular systems